oxiracetam
Sign in to saveOxiracetam (developmental code name ISF 2522) is a nootropic drug of the racetam family and a very mild stimulant. Several studies suggest that the substance is safe even when high doses are consumed for a long period of time. However, the mechanism of action of the racetam drug family is still a matter of research. Oxiracetam is not approved by Food and Drug Administration for any medical use in the United States.
Research
220 papers- Oxiracetam alleviates anti-inflammatory activity and ameliorates cognitive impairment in the early phase of traumatic brain injury.Acta neurochirurgica · 2023
- Efficacy and safety of L-oxiracetam on cognitive function in patients with traumatic brain injury: a multicentre, randomised, double-blind, phase 3 clinical trial.Signal transduction and targeted therapy · 2025
- [Oxiracetam].Giornale di clinica medica · 1989
- Oxiracetam and physical activity in preventing cognitive decline after stroke: A multicenter, randomized controlled trial.European stroke journal · 2025
- Co-administration of Nanowired Oxiracetam and Neprilysin with Monoclonal Antibodies to Amyloid Beta Peptide and p-Tau Thwarted Exacerbation of Brain Pathology in Concussive Head Injury at Hot Environment.Advances in neurobiology · 2023
via PubMed
Wikidata facts
- Mass
- 158.069
Show 3 more facts
- chemical formula
- C₆H₁₀N₂O₃
- canonical SMILES
- C1C(CN(C1=O)CC(=O)N)O
- Commons category
- Oxiracetam
Sources (2)
via Wikidata · CC0
~3 min read
Article
5 sectionsContents
- Clinical findings
- Pharmacokinetics
- References
- Further reading
- External links
Oxiracetam (developmental code name ISF 2522) is a nootropic drug of the racetam family and a very mild stimulant. Several studies suggest that the substance is safe even when high doses are consumed for a long period of time. However, the mechanism of action of the racetam drug family is still a matter of research. Oxiracetam is not approved by Food and Drug Administration for any medical use in the United States.
==Clinical findings== Oxiracetam has been studied to determine if it has an effect on symptoms of dementia, but no consistent results were obtained in patients with Alzheimer's dementia or organic solvent abuse.